COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
about
Lymphatic Vessels, Inflammation, and Immunity in Skin CancerInhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertensionChronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast CancerTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesCyclooxygenase-2 and the inflammogenesis of breast cancer.A novel role for ezrin in breast cancer angio/lymphangiogenesis.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.Lymphangiogenesis and lymphatic metastasis in breast cancer.Inflammatory lymphangiogenesis in postpartum breast tissue remodelingCo-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implicationsThe number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancerEffect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancerThe role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formationProstaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsMacrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Increased lymphangiogenesis in joints of mice with inflammatory arthritisLymphangiogenesis and lymph node metastasis in breast cancerMigration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Potential therapeutic strategies for lymphatic metastasis.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionInduction of myeloid-derived suppressor cells by tumor exosomes.Role of p38 MAP Kinase Signal Transduction in Solid TumorsModulation of lymphangiogenesis: a new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review.The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis.Lymphangiogenesis and lymphatic vessel remodelling in cancer.Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach.Bevacizumab Modulation of the Interaction Between the MCF-7 Cell Line and the Chick Embryo Chorioallantoic Membrane.Systemic Levels of Estrogens and PGE2 Synthesis in Relation to Postmenopausal Breast Cancer Risk.
P2860
Q26778332-9FEB2327-FD85-45F1-8461-D31D3B30CCD7Q27331781-DC11CB5B-1CC6-48EB-A170-A3F8A1D05A80Q27333172-009692AD-CEF0-4D23-9F1B-0F73DE0194CBQ28072448-47A3A565-6BBC-4BBE-AA1C-D674A52BF04EQ28085631-0A1063A7-35B0-4A0E-AC20-CBDBA159E23BQ30367680-4AE4FC07-15AD-4A6A-983A-E2AFFC7BE395Q30617722-8F0626F4-B9F5-4E89-9BE9-16DA7B2E142AQ33314445-F200FAE2-DC4B-4FB6-9AF5-F39B581610ADQ33555154-4ABFB0A4-260C-433C-B349-F2CD09F36488Q33814571-81B501CF-591C-4901-BF28-16AC6F7CA90DQ33940058-DADD79C3-B26C-4349-AB34-094CB8C06FA1Q34117518-8D6A3462-869F-41C0-A059-B36DB65820F0Q34251088-FEF40251-9275-4E51-87C1-5CE29FA22E3DQ34326240-57645664-7EDE-4258-B512-E111AE05B457Q34567287-EF700FBD-3C13-4117-9BCA-B81ACDF0F8A2Q34572806-01AF857B-F47A-40E0-9411-D81523DFDF0AQ34733346-7282B754-DA0B-444F-AB46-30F1222579FEQ35117974-8CFA8AE5-B5A1-4373-A295-C40A47B711C4Q35219125-0685DA9F-F914-4B6B-827E-C46AD39028C9Q35501362-BD18000A-E800-4F5B-BEED-C69A5C98DB70Q35713568-3B0B0EF1-1786-468E-90DA-D08082A126A7Q36198192-0D76660E-8E5E-493D-A59B-54E5E22FB128Q36241115-DC88F6F8-10A4-409D-A680-2D529C82D196Q36339264-4C79422A-63A7-4182-B25E-8778C280C14FQ36465469-50346CDE-3BE5-4FC3-BA95-DCBE8DF6BDDFQ36515990-1DB34159-BD21-4809-A3FC-4A4FCCE29154Q36611431-DD9C288E-93DF-4867-BB4F-E77A42C127CBQ36806255-B0505859-BB89-42A1-BB10-4F389A34A9A3Q36808641-A2800A0D-C5EC-4ADA-89E3-85B12CE2E313Q36851512-0E07265F-BD29-43BA-92E1-CF9E1C836A84Q37071029-DF7CAEFA-823C-4D8F-B8F2-ED9BC02F98B6Q37375966-FF633230-856D-4764-8FD4-ECBB9383876CQ37392558-4A893E5E-9A2D-455E-8C67-2E8C70B46B2AQ37969041-9D309B8D-99DA-4782-8CF1-9A19C74D1038Q38054491-55840862-A7E5-498E-8635-FF3DC4EDD299Q38190359-0E6649EA-6F7D-4808-9E78-729796B4D644Q38339742-7485C6FD-0DF6-4346-A7C1-ED476CA4B9B1Q38436710-162D0A17-D446-4754-9866-99E9F1BE1566Q38709589-057A486A-C6AE-4D63-8B17-437C394BEB2FQ38793447-4214A1CA-D1B5-4FC3-A550-F1D74EF295ED
P2860
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@ast
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@en
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@nl
type
label
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@ast
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@en
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@nl
prefLabel
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@ast
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@en
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@nl
P2093
P2860
P3181
P356
P1476
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
@en
P2093
C Chakraborty
G F Wagner
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6603067
P407
P577
2006-04-01T00:00:00Z
P5875
P6179
1006690528